The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

But sufferers are being given major hope thanks to a new NHS trial that could see a groundbreaking treatment eradicate the ...

DelveInsight's 'Systemic Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of pipeline ...

If antimalarials do not do the trick, your provider may try one of these systemic treatments: An immunosuppressive, such as methotrexate or mycophenolate mofetil (MMF) A systemic retinoid (such as ...

For severe cases or when organ systems are involved, treatment may include: Immunosuppressive drugs: Medications such as azathioprine, methotrexate, cyclosporine, mycophenolate mofetil, and ...

Lupus anticoagulant tests are in vitro coagulation tests that rely on the phospholipids ... No statistically significant changes were detected in other immunosuppressive drugs used as medical ...

Antimalarials, used in the past principally for lupus skin and joint involvement, are now recognized to prevent the occurrence of flares, the accumulation of damage, and the occurrence of early ...

Systemic lupus erythematosus is a potentially fatal ... Patients are treated with immunosuppressive drugs. During the past year, four studies have reported ten mutations in UNC93B1, which encodes ...